Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treatment optimisation in multiple sclerosis.

M Zaffaroni1

  • 1Centro Studi Sclerosi Multipla, Ospedale S. Antonio Abate, Via Pastori 4, I-21013, Gallarate, Italy. centro.sm@aogallarate.it

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|January 3, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Penalized-Survival Nomogram Predicts 5-Year Metastasis-Free Survival After Salvage Radiotherapy for Postprostatectomy Patients: A Multicenter Study.

Clinical genitourinary cancer·2025
Same author

Home-based, computer-assisted cognitive rehabilitation for attention in pediatric onset multiple sclerosis: a randomized, multicenter pilot study.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2024
Same author

Patients' needs in proton therapy: A survey among ten European facilities.

Clinical and translational radiation oncology·2023
Same author

Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2022
Same author

Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration.

Journal of neurology·2021
Same author

Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2021
Same journal

Hypogonadotrophic hypogonadism in GBA2 associated spastic paraplegia type 46 (SPG46): a phenotypic expansion.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Vibrotactile stimulation induces changes in basal ganglia output, cervical muscle activity, and head posture in a patient with cervical dystonia.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Evaluating LLM diagnostic reasoning: a new frontier for clinical AI assessment.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Asymmetrical muscular disorder with normal creatine kinase (CK) and electromyography (EMG): the challenging diagnosis of muscular polyarteritis nodosa (MPAN), case report and literature review.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Neuropsychological assessment in adult epilepsy: rationale, test selection, and clinical integration across non-surgical care in Italian patients.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Early implementation of transradial mechanical thrombectomy in a primary stroke center: a sequential cohort propensity score-matched study.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
See all related articles

Identifying patients with multiple sclerosis (MS) who do not respond to disease-modifying agents (DMA) is crucial. Further validation of criteria is needed to optimize MS treatment strategies for individual patients.

Area of Science:

  • Neurology
  • Immunology
  • Medical Treatment

Background:

  • Multiple sclerosis (MS) patients exhibit variable responses to disease-modifying agents (DMA).
  • Optimizing MS treatment requires reliable criteria to distinguish between responders and non-responders.
  • Current indicators include disease natural history, clinical evolution, and MRI, with potential future markers like antibodies and genetic factors.

Purpose of the Study:

  • To highlight the need for robust criteria to identify suboptimal responses to MS disease-modifying agents (DMA).
  • To discuss potential indicators for assessing treatment efficacy in multiple sclerosis.
  • To emphasize the necessity of experimental validation for proposed consensus criteria.

Main Methods:

  • Review of existing indicators for treatment response in multiple sclerosis.

Related Experiment Videos

  • Analysis of proposed international consensus criteria for suboptimal DMA response.
  • Discussion of potential future biomarkers including immunological and genetic factors.

    • Main Results:

    • No single definitive method currently exists to reliably identify all non-responders to MS DMA.
    • Proposed criteria for suboptimal response require experimental validation.
    • Multiple factors including clinical, radiological, immunological, and genetic aspects may inform treatment decisions.

    Conclusions:

    • Establishing clear, validated guidelines is essential for optimizing multiple sclerosis treatment with DMA.
    • Further research is needed to validate proposed criteria and explore novel biomarkers.
    • Personalized treatment strategies are key to improving outcomes for MS patients.